[1]
|
M. Roy, et al., “Anticlastogenic, Antigenotoxic and Apoptotic Activity of Epigallocatechin Gallate: A Green Tea Polyphenol,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 523-524, 2003, pp. 33-41.
|
[2]
|
T. Kundu, et al., “Induction of Apoptosis in Human Leukemia Cells by Black Tea and Its Polyphenol Theaflavin,” Cancer Letters, Vol. 230, No. 1, 2005, pp. 111-121.
doi:10.1016/j.canlet.2004.12.035
|
[3]
|
T. Otsuka, et al., “Growth Inhibition of Leukemic Cells by (?)-Epigallocatechin Gallate, the Main Constituent of Green Tea,” Life Sciences, Vol. 63, No. 16, 1998, pp. 1397-1403. doi:10.1016/S0024-3205(98)00406-8
|
[4]
|
I. K. Wang, S. Y. Lin-Shiau and J. K. Lin, “Induction of Apoptosis by Apigenin and Related Flavonoids through Cytochrome C Release and Activation of Caspase-9 and Caspase-3 in Leukaemia HL-60 Cells,” European Journal of Cancer, Vol. 35, No. 10, 1999, pp. 1517-1525.
doi:10.1016/S0959-8049(99)00168-9
|
[5]
|
S. J. Lee, J.-H. Yoon and K. S. Song, “Chrysin Inhibited Stem Cell Factor (SCF)/c-Kit Complex-Induced Cell Proliferation in Human Myeloid Leukemia Cells,” Biochemical Pharmacology, Vol. 74, No. 2, 2007, pp. 215-225.
doi:10.1016/j.bcp.2007.04.011
|
[6]
|
K. J. Woo, et al., “Chrysin-Induced Apoptosis Is Mediated through Caspase Activation and Akt Inactivation in U937 Leukemia Cells,” Biochemical and Biophysical Research Communications, Vol. 325, No. 4, 2004, pp. 1215-1222. doi:10.1016/j.bbrc.2004.09.225
|
[7]
|
Y. H. Siddique, T. Beg and M. Afzal, “Antigenotoxic Effect of Apigenin against Anti-Cancerous Drugs,” Toxicology in Vitro, Vol. 22, No. 3, 2008, pp. 625-631.
doi:10.1016/j.tiv.2007.12.002
|
[8]
|
D. Montgomery, “Design and Analysis of Experiments,” 6th Edition, Wiley, Berlin, 2005, p. 672.
|
[9]
|
K. Hinkelmann and O. Kempthorne, “Design and Analysis of Experiments,” Advanced Experimental Design, John Wiley & Sons, Inc., Hoboken, 2005.
doi:10.1002/0471709948
|
[10]
|
J. P. Groten, E. D. Schoen and V. J. Feron, “Use of Factorial Designs in Combination Toxicity Studies,” Food and Chemical Toxicology, Vol. 34, No. 11? 1996, pp. 1083-1089.
|
[11]
|
F. K. H. Phoa, H. Xu and W. K. Wong, The Use of Non-regular Fractional Factorial Designs in Combination Toxicity Studies,” Food and Chemical Toxicology, Vol. 47, No. 9, 2009, pp. 2183-2188.
doi:10.1016/j.fct.2009.06.003
|
[12]
|
N. F. Kolachi, et al., “Multivariate Optimization of Cloud Point Extraction Procedure for Zinc Determination in Aqueous Extracts of Medicinal Plants by Flame Atomic Absorption Spectrometry,” Food and Chemical Toxicology, Vol. 49, No. 10, 2011, pp. 2548-2556.
doi:10.1016/j.fct.2011.06.065
|
[13]
|
M. Lim and A. Mantalaris, “Development of a Design of Experiment Methodology: Applications to the Design and Analysis of Experiments,” In: J. M. Polak, Ed., Advances in Tissue Engineering, Imperial College Press, London, 2008. doi:10.1142/9781848161832_0011
|
[14]
|
R. H. Myers and D. C. Montgomery, “Two-Level Fractional Factorial Designs, in Response Surface Methodology: Process and Product Optimization Using Designed Experiments,” John Wiley & Sons, Inc., Hoboken, 2002.
|
[15]
|
K. Hinkelmann and O. Kempthorne, “Confounding in 2n Factorial Designs, in Design and Analysis of Experiments,” John Wiley & Sons, Inc., Hoboken, 2005.
doi:10.1002/0471709948.ch12
|
[16]
|
M. J. Anderson and P. J. Whitcomb, “DOE Simplified: Practical Tools for Effective Experimentation,” 2nd Edition, Productivity Press, London, 2007, p. 241.
|
[17]
|
R. W. Mee and M. Peralta, “Semifolding 2k-p Designs,” Technometrics, Vol. 42, No. 2, 2000, pp. 122-134.
|
[18]
|
N. Balakrishnan and P. Yang, “De-Aliasing Effects Using Semifoldover Techniques,” Journal of Statistical Planning and Inference, Vol. 139, No. 9, 2009, pp. 3102-3111.
doi:10.1016/j.jspi.2009.02.010
|
[19]
|
O. Tajima, et al., “Statistically Designed Experiments in a Tiered Approach to Screen Mixtures of Fusarium Mycotoxins for Possible Interactions,” Food and Chemical Toxicology, Vol. 40, No. 5, 2002, pp. 685-695.
doi:10.1016/S0278-6915(01)00124-7
|
[20]
|
V. Cortin, et al., “Efficient in Vitro Megakaryocyte Maturation Using Cytokine Cocktails Optimized by Statistical Experimental Design,” Experimental Hematology, Vol. 33, No. 10, 2005, pp. 1182-1191.
doi:10.1016/j.exphem.2005.06.020
|
[21]
|
M. Lim, et al., “Optimization of in Vitro Erythropoiesis from CD34+ Cord Blood Cells Using Design of Experiments (DOE),” Biochemical Engineering Journal, Vol. 55, No. 3, 2011, pp. 154-161.
doi:10.1016/j.bej.2011.03.014
|
[22]
|
C. S. Yang, et al., “Cancer Prevention by Tea: Evidence from Laboratory Studies,” Pharmacological Research, Vol. 64, No. 2, 2011, pp. 113-122.
doi:10.1016/j.phrs.2011.03.001
|
[23]
|
K.-S. Chen, et al., “Tannic Acid-Induced Apoptosis and Enhanced Sensitivity to Arsenic Trioxide in Human Leukemia HL-60 Cells,” Leukemia Research, Vol. 33, No. 2, 2009, pp. 297-307. doi:10.1016/j.leukres.2008.08.006
|